VRTX

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain.

Vertex Pharmaceuticals Incorporated (VRTX) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $403.16 and $563.80.

• Healthcare
• Biotechnology
• Boston, United States
• 6.4K employees
• Led by Jeffrey Marc Leiden M.D., Ph.D.